Vertex buys developer of preclinical cell therapy for Type 1 diabetes for $950M - MedCity News
Vertex to acquire ViaCyte, targeting type 1 diabetes
Engineering islets from stem cells for advanced therapies of diabetes | Nature Reviews Drug Discovery
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells - ScienceDirect
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
Vertex – type 1 diabetes vs stem cell therapy - The Boar
International Medical Students' Research Association - The new remarkable treatment for Type 1 diabetes! Type 1 diabetes (T1D) is a chronic condition in which the pancreas produces little or no insulin. Insulin
Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte
Vertex: Trial of New Type 1 Diabetes Cell Therapy Put on Hold - DSM
Frontiers | Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes
Vertex snaps up diabetes stem cell rival | Nature Biotechnology
Vertex builds up pipeline of type 1 diabetes cell therapies with $320M buyout - MedCity News
How stem cells could fix type 1 diabetes
Stem Cells and the Search For a Type 1 Diabetes Cure
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - The New York Times
Vertex's Stem Cell-Based Type 1 Diabetes Therapy To Enter Human Trial Stage | The Healthcare Technology Report.
Vertex Type 1 Diabetes Research Stirs Hope for Stem Cell-Based 'Cure'
Vertex: New Stem Cell Based Type 1 Diabetes Treatment Shown Effective in First Patient - DSM
Vertex Releases New Data on Potential Cure for Type 1 Diabetes
Clinical Trial Tests Stem Cell Therapy to Cure People with Type 1 Diabetes
Emerging diabetes therapies: Bringing back the β-cells - ScienceDirect
Vertex reports positive results for first patient in Type 1 diabetes trial - The Boston Globe
